IW, D., B, G., K, L., JS, L., TA, R., J, S., . . . J, X. (2021). Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nature biotechnology, 39(9), 1115. https://doi.org/10.1038/s41587-021-00857-z
Chicago Style (17th ed.) CitationIW, Deveson, et al. "Evaluating the Analytical Validity of Circulating Tumor DNA Sequencing Assays for Precision Oncology." Nature Biotechnology 39, no. 9 (2021): 1115. https://doi.org/10.1038/s41587-021-00857-z.
MLA (9th ed.) CitationIW, Deveson, et al. "Evaluating the Analytical Validity of Circulating Tumor DNA Sequencing Assays for Precision Oncology." Nature Biotechnology, vol. 39, no. 9, 2021, p. 1115, https://doi.org/10.1038/s41587-021-00857-z.
Warning: These citations may not always be 100% accurate.